Form 4: Hims & Hers Health Director Payne Acquires 30,120 Restricted Stock Units

Director Christopher D. Payne acquired 30,120 restricted stock units in Hims & Hers Health, Inc., subject to a three-year vesting schedule.

Summary

• On May 8, 2024, Christopher D. Payne, a director of Hims & Hers Health, Inc., acquired 30,120 Restricted Stock Units (RSUs).
• These RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
• The RSUs are subject to a service-based vesting requirement over a 3-year period.
• Specifically, 1/3 of the RSUs will vest on June 15, 2025, another 1/3 on June 15, 2026, and the final 1/3 on June 15, 2027.
• Following the transaction, Payne directly owns 30,120 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard equity grant to a director, which is generally viewed as a positive sign of alignment with shareholder interests.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.
• The vesting schedule aligns the director's interests with the long-term success of the company.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule suggests a multi-year commitment from the director.

Industry Context

This is a standard SEC Form 4 filing, reflecting a common practice of granting equity compensation to directors to align their interests with those of shareholders. This is a common practice in the health and wellness industry to attract and retain talent.

Comparison to Industry Standards

• Equity compensation for directors is a common practice across publicly traded companies, including those in the telehealth and wellness sectors.
• Companies like Teladoc Health and GoodRx also utilize stock options and restricted stock units as part of their director compensation packages.
• The vesting schedules for these grants typically range from one to four years, aligning with industry norms.

Stakeholder Impact

• Shareholders may view the equity grant as a positive sign of alignment between management and shareholder interests.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates